| |
| |
|
| Insider
Information: |
Titus Gary |
| Relationship: |
Director |
| City: |
Sunnyvale |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
67,728 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,718 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
67,728 |
|
|
| Total
Value |
$1,718 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Nuvelo Inc |
ABIO |
Chief Acct.Officer |
2006-08-30 |
2,633 |
|
0 |
Premium* |
|
|
Sciclone Pharmaceuticals Inc |
SCLN |
Senior VP Finance & CFO |
2012-06-15 |
37,095 |
2008-12-11 |
0 |
Premium* |
|
|
ImmunoCellular Therapeutics Ltd |
IMUC |
Director |
2015-09-18 |
28,000 |
2013-12-20 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| IMUC |
ImmunoCellular Therapeuti... |
Director |
– • – |
2015-09-18 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
28,000 |
0 |
- |
|
| IMUC |
ImmunoCellular Therapeuti... |
Director |
– • – |
2013-12-20 |
4 |
B |
$0.78 |
$14,040 |
D/D |
18,000 |
18,000 |
2.39 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
Senior VP Finance & CFO |
• – – |
2012-06-15 |
4 |
S |
$6.99 |
$465,380 |
D/D |
(66,578) |
37,095 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
Senior VP Finance & CFO |
• – – |
2012-06-15 |
4 |
OE |
$0.95 |
$63,249 |
D/D |
66,578 |
66,719 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
Senior VP Finance & CFO |
• – – |
2012-06-14 |
4 |
OE |
$0.95 |
$14,278 |
D/D |
15,029 |
52,124 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
Senior VP Finance & CFO |
• – – |
2012-06-14 |
4 |
S |
$7.05 |
$105,954 |
D/D |
(15,029) |
37,095 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
Senior VP Finance & CFO |
• – – |
2012-05-31 |
4 |
B |
$3.84 |
$1,003 |
D/D |
261 |
37,095 |
2.66 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
Senior VP Finance & CFO |
• – – |
2012-05-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,357 |
36,834 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
Senior VP Finance & CFO |
• – – |
2012-02-29 |
4 |
B |
$3.78 |
$912 |
D/D |
241 |
27,477 |
2.66 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
Senior VP Finance & CFO |
• – – |
2011-11-30 |
4 |
B |
$3.78 |
$912 |
D/D |
241 |
27,236 |
2.66 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
Senior VP Finance & CFO |
• – – |
2011-08-31 |
4 |
B |
$3.98 |
$911 |
D/D |
229 |
26,995 |
2.66 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
Senior VP Finance & CFO |
• – – |
2011-08-18 |
4 |
B |
$4.65 |
$4,999 |
D/D |
1,075 |
26,766 |
2.66 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
Senior VP Finance & CFO |
• – – |
2011-06-15 |
4 |
B |
$4.93 |
$10,891 |
D/D |
2,197 |
25,691 |
2.74 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
Senior VP Finance & CFO |
• – – |
2011-05-31 |
4 |
B |
$3.60 |
$928 |
D/D |
258 |
23,494 |
2.66 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
CFO & Sr. VP Finance |
• – – |
2011-02-28 |
4 |
B |
$3.29 |
$1,352 |
D/D |
411 |
23,236 |
2.66 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
CFO & Sr. VP Finance |
• – – |
2010-11-30 |
4 |
B |
$2.15 |
$578 |
D/D |
269 |
22,825 |
2.66 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
CFO & Sr. VP Finance |
• – – |
2010-08-31 |
4 |
B |
$2.05 |
$883 |
D/D |
431 |
22,556 |
2.66 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
Senior VP Finance & CFO |
• – – |
2010-05-11 |
4 |
B |
$3.39 |
$8,475 |
D/D |
2,500 |
22,125 |
2.74 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
Senior VP Finance & CFO |
• – – |
2009-05-22 |
4 |
B |
$1.73 |
$8,035 |
D/D |
4,625 |
19,625 |
2.74 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
Senior VP Finance & CFO |
• – – |
2008-12-12 |
4 |
B |
$1.02 |
$10,200 |
D/D |
10,000 |
15,000 |
2.74 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
Senior VP Finance & CFO |
• – – |
2008-12-11 |
4 |
B |
$1.00 |
$4,980 |
D/D |
5,000 |
5,000 |
2.66 |
- |
|
| ABIO |
Nuvelo Inc |
Chief Acct.Officer |
• – – |
2006-08-30 |
4 |
S |
$20.70 |
$289,800 |
D/D |
(14,000) |
2,633 |
0 |
- |
|
| ABIO |
Nuvelo Inc |
Chief Acct.Officer |
• – – |
2006-08-30 |
4 |
OE |
$2.60 |
$36,330 |
D/D |
14,000 |
16,633 |
0 |
- |
|
| ABIO |
Nuvelo Inc |
Chief Acct.Officer |
• – – |
2006-08-29 |
4 |
S |
$20.65 |
$141,060 |
D/D |
(6,831) |
2,633 |
|
- |
|
| ABIO |
Nuvelo Inc |
Chief Acct.Officer |
• – – |
2006-08-29 |
4 |
OE |
$9.17 |
$62,606 |
D/D |
6,831 |
9,464 |
|
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
